Phyto-oestrogens through the life cycle

Proceedings of the Nutrition Society

Volumn 59, Issue 3, 2000, Pages 489-496

  Cassidy, Aedin ^a,b   Faughnan, Marian ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b UNILEVER RESEARCH   (United Kingdom)

Author keywords

Isoflavones; Lignans; Phyto oestrogens; Soyabean

Indexed keywords

ESTROGEN RECEPTOR; PHYTOESTROGEN;

BIOAVAILABILITY; CONFERENCE PAPER; DIETARY INTAKE; HORMONE ACTION; HORMONE METABOLISM; HORMONE SUBSTITUTION; LIFE CYCLE; MENOPAUSE; RISK BENEFIT ANALYSIS;

EID: 0033815979     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0029665100000719     Document Type: Conference Paper

References (104)

1. Inhibition of human aromatase by mammalian lignans and isoflavanoid phytoestrogens
2. Dietary phytoestrogens and cancer: In vitro and in vivo studies
3. Maternal and neonatal phytoestrogens in Japanese women during birth
4. Biphasic effect of genistein on bone tissue in the ovariectomized, lactating rat model
5. The effects of dietary soy supplementation on hot flushes
6. Meta-analysis of the effects of soy protein intake on serum lipids
7. Comparison of soy phyto-estrogens and oestrogens on atherosclerosis progression in postmenopausal monkeys
8. Soy protein versus soy phyto-estrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynamolgus monkeys
9. Soyabean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys
10. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis
11. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats
12. An extract of soy flour influences serum cholesterol and thyroid hormones in rats and hamsters
13. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell LDL receptor mRNA in hypercholesterolaemic postmenopausal women
14. Production and metabolism of lignans by the human faecal flora
15. Genistein modulates neuroblastoma cell proliferation and differentiation through induction of apotosis and regulation of tyrosine kinase activity and N-myc expression
16. Short-term effects of phyto-estrogen-rich diets on postmenopausal women
17. Physiological effects of phyto-oestrogens in relation to cancer and other human health risks
18. Biological effects of isoflavones present in soy in premenopausal women: Implications for the prevention of breast cancer
19. Biological effects of isoflavones in young women - The importance of the chemical composition of soya products
20. Hormonal effects of phytoestrogens in postmenopausal women and middle-aged men
21. Phyto-estrogens: A potential role in the prevention of CHD
22. Can soy supplementation substitute for traditional hormone replacement therapy?
23. Patient-specific decisions about HRT in postmenopausal women
24. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women
25. Genistein and daidzein, and their β-glycoside conjugates: Antitumor isoflavones in soyabean foods from American and Asian diets
26. Soy protein containing isoflavones reduce plasma concentrations of lipids and lipoprotein
27. Soybean isoflavones: Effect of environment and variety on composition
28. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene
29. Inhibition of 5α-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavanoids
30. The effect of postmenopausal estrogen therapy on bone density in elderly women
31. Phytoestrogens and inhibition of angiogenesis
32. Oestrogenic responses in normal postmenopausal women to administration of the phytoestrogens in bourbon whiskey
33. Phytoestrogens and diseases of the prostate gland
34. Flavanoids
35. Body measurements, bone mass and fractures - Does the East differ from the West
36. Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques
37. Aromatase inhibition by flavanoids
38. Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calcium-deficient diet
39. A urinary profile study of dietary phytoestrogens
40. The variable metabolic response in dietary isoflavones in humans
41. Dietary habits and mortality in 11000 vegetarians and health conscious people: Results of a 17 year follow up
42. Mechanisms of action of the soy isoflavone genistein: Emerging role of its effects through transforming growth factor beta signalling
43. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans
44. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice
45. The effects of Promensil TM, an isoflavone extract on menopausal symptoms
46. Malonyl isoflavone glycosides in soyabean seeds (Glycine max merrill)
47. Cloning of a novel receptor expressed in rat prostate and ovary
48. The novel estrogen receptor-beta subtype potential role in the cell and promotor specific actions of estrogens and anti-estrogens
49. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta
50. Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity
51. Genistein suppresses mammary cancer in rats
52. Genistein studies in rats: Potential for breast cancer prevention and reproductive and developmental toxicity
53. Urinary equol excretion with a soy challenge: Influence of habitual diet
54. The effects of genistein on platelet function are due to thromboxane receptor antagonism rather than inhibition of tyrosine kinase
55. Dietary soyabean may be antiestrogenic in male mice
56. Differentiation between vasculoprotective and uterotrophic effects of ligands with different affinities to estrogen receptors alpha and beta
57. Soy intake and cancer risk: A review of the in vivo and in vitro data
58. Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer
59. Measurement and metabolism of isoflavanoids and lignans in human male
60. Genistein is an effective stimulator of sex hormone-binding globulin production in hepatocarcinoma human liver cancer cells and suppresses proliferation of these cells in culture
61. Dietary flour supplementation decreases postmenopausal hot flushes - Effect of soy and wheat
62. Tyrosine-kinase activity in rabbit platelets stimulated with platelet-activating factor. The effect of inhibiting tyrosine kinase with genistein on platelet-signalling-molecule elevation and functional responses
63. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats
64. Decreased total serum cholesterol concentration is associated with high intake of soy products in Japanese men and women
65. An in vitro and in vivo study of antitumour effects of genistein on hormone refractory prostate cancer
66. A new isoflavone from soyabean
67. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women
68. Soy isoflavones improve arterial compliance but not plasma lipids in menopausal and postmenopausal women
69. Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and multi-drug resistance gene
70. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor autophosphorylation
71. Effect of flaxseed ingestion on the menstrual cycle
72. Influence of isoflavones in soy isoflavones protein isolates on development of induced prostate-related cancers in L-W rats
73. Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women
74. Flavones and isoflavones in inducing substances of legume modulation
75. Antioxidant activity of phytoestrogenic isoflavones
76. Isoflavones and postmenopausal bone health: A viable alternative to estrogen therapy
77. Genistein inhibition of prostate cancer cell growth and metastasis in vivo
78. Naturally occuring non-steroidal estrogens of dietary origin
79. Non-steroidal estrogens of dietary origin: Possible roles in health and disease, metabolism and physiological effects
80. Non-steroidal oestrogens of dietary origin: Possible roles in hormone dependent disease
81. Dietary isoflavones - Biological effects and relevance to human health
82. Exposure of infants to phyto-estrogens from soy-based infant formulas
83. Serum levels of prostatic specific antigen among Japanese-American men
84. Steroid and phytoestrogen binding to sheep uterine receptors
85. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
86. Clinical symptoms of estrogen deficiency
87. Potential health benefits of dietary phytoestrogens: A review of clinical, epidemiological, and mechanistic evidence
88. Mammalian lignan production from various foods
89. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance
90. A comparison of bone mineral density between Caucasian, Asian and Afro-Caribbean women
91. Lignans and flavanoids inhibit aromatase enzyme in human preadipocytes
92. Soy isoflavones decrease the high-fat promoted growth of human prostate cancer. Results from in vivo and animal studies
93. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women
94. Oestrogen effects of plant derived foods in postmenopausal women
95. Thrombotic mechanisms in atherosclerosis: Potential impact of soy
96. Cardiovascular risk factors in women
97. Dietary soy isoflavones inhibit in-vivo constrictor responses of coronary arteries to collagen-induced platelet activation
98. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women
99. Latent prostatic carcinoma: Pathological and epidemiological aspects
100. Soy and rye diets inhibit the development of Dunning R3327 prostatic adenocarcinoma in rats
101. Soybean components inhibit the growth of human prostate cancer cell line LNCaP in SCID mice via alteration in cell apoptosis, angiogenesis and proliferation